Prokarium to attend Swiss Biotech Day

Prokarium’s CEO, Kristen Albright, will attend Swiss Biotech Day in Basel on 22nd April.

Related News

Prokarium appoints Ibs Mahmood as Chief Executive Officer

London, UK – November 11, 2025 – Prokarium, a clinical-stage biopharmaceutical company pioneering the field of microbial immunotherapy, today announced the...

Prokarium expands IP portfolio with two new U.S. patents strengthening its position in bladder cancer

LONDON, United Kingdom, November 1, 2024 – Prokarium, a biopharmaceutical company developing innovative cancer treatments, today announced the...

Prokarium expands IP portfolio with two new U.S. patents strengthening its position in bladder cancer

LONDON, United Kingdom, November 1, 2024 – Prokarium, a biopharmaceutical company developing innovative cancer treatments, today announced the...

Prokarium Secures UKRI Grant to Fund Development of Living Cures Platform

LONDON, UK, March 14, 2024 – Prokarium announces they have been awarded a UK Research and Innovation (UKRI) Engineering Biology...

Prokarium Secures UKRI Grant to Fund Development of Living Cures Platform

LONDON, UK, March 14, 2024 – Prokarium announces they have been awarded a UK Research and Innovation (UKRI) Engineering Biology...